316 related articles for article (PubMed ID: 20473947)
1. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis.
Tan JX; Wang XY; Su XL; Li HY; Shi Y; Wang L; Ren GS
PLoS One; 2011; 6(7):e22836. PubMed ID: 21829529
[TBL] [Abstract][Full Text] [Related]
3. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
[TBL] [Abstract][Full Text] [Related]
4. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
Lokeshwar VB; Rubinowicz D; Schroeder GL; Forgacs E; Minna JD; Block NL; Nadji M; Lokeshwar BL
J Biol Chem; 2001 Apr; 276(15):11922-32. PubMed ID: 11278412
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.
Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G
Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395
[TBL] [Abstract][Full Text] [Related]
6. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
Hautmann SH; Lokeshwar VB; Schroeder GL; Civantos F; Duncan RC; Gnann R; Friedrich MG; Soloway MS
J Urol; 2001 Jun; 165(6 Pt 1):2068-74. PubMed ID: 11371930
[TBL] [Abstract][Full Text] [Related]
7. [Effect of silencing of hyaluronidase gene HYAL1 by RNA interference on proliferation of human breast cancer cells].
Tan JX; Ren GS; Tu G; Li XT; Wang XY; Ran L
Ai Zheng; 2006 Jul; 25(7):844-8. PubMed ID: 16831275
[TBL] [Abstract][Full Text] [Related]
8. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
[TBL] [Abstract][Full Text] [Related]
9. HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.
Lokeshwar VB; Estrella V; Lopez L; Kramer M; Gomez P; Soloway MS; Lokeshwar BL
Cancer Res; 2006 Dec; 66(23):11219-27. PubMed ID: 17145867
[TBL] [Abstract][Full Text] [Related]
10. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
11. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
[TBL] [Abstract][Full Text] [Related]
12. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
13. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Lokeshwar VB; Young MJ; Goudarzi G; Iida N; Yudin AI; Cherr GN; Selzer MG
Cancer Res; 1999 Sep; 59(17):4464-70. PubMed ID: 10485499
[TBL] [Abstract][Full Text] [Related]
14. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.
Ye L; Sun PH; Malik MF; Mason MD; Jiang WG
J Cancer Res Clin Oncol; 2014 Jun; 140(6):957-67. PubMed ID: 24667935
[TBL] [Abstract][Full Text] [Related]
15. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
Li Y; Li L; Brown TJ; Heldin P
Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
[TBL] [Abstract][Full Text] [Related]
16. Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.
Witzel I; Marx AK; Müller V; Wikman H; Matschke J; Schumacher U; Stürken C; Prehm P; Laakmann E; Schmalfeldt B; Milde-Langosch K; Oliveira-Ferrer L
Breast Cancer Res Treat; 2017 Apr; 162(3):427-438. PubMed ID: 28168629
[TBL] [Abstract][Full Text] [Related]
17. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
Jiang G; Zhang X; Zhang Y; Wang L; Fan C; Xu H; Miao Y; Wang E
Tumour Biol; 2015 Sep; 36(10):7881-9. PubMed ID: 25953261
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
Posey JT; Soloway MS; Ekici S; Sofer M; Civantos F; Duncan RC; Lokeshwar VB
Cancer Res; 2003 May; 63(10):2638-44. PubMed ID: 12750291
[TBL] [Abstract][Full Text] [Related]
19. Eps8 regulates cellular proliferation and migration of breast cancer.
Chen C; Liang Z; Huang W; Li X; Zhou F; Hu X; Han M; Ding X; Xiang S
Int J Oncol; 2015 Jan; 46(1):205-14. PubMed ID: 25333707
[TBL] [Abstract][Full Text] [Related]
20. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
